AngioDynamics

Quarterly Financials

Values in thousands 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Revenue
$80,158
$72,004
$72,845
$67,491
Gross Profit
39,630
36,259
37,344
34,154
EBITDA
-277
1,910
-3,985
-5,880
EBIT
-6,110
-4,409
-10,848
-12,665
Net Income
-6,050
-4,407
-10,738
-12,798
Net Change In Cash
80,158
72,004
72,845
67,491
Free Cash Flow
21,222
-16,347
512
-20,658
Cash
55,893
44,760
54,089
55,005
Basic Shares
40,984
40,853
40,922
40,653

Annual Financials

Values in thousands 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Revenue
$292,498
$303,914
$338,752
$316,219
Gross Profit
147,387
154,698
174,246
165,732
EBITDA
-8,232
-6,132
12,194
11,132
EBIT
-34,032
-33,844
-18,679
-18,217
Net Income
-33,993
-184,349
-52,442
-26,547
Net Change In Cash
292,498
303,914
338,752
316,219
Cost of Revenue
15,752
-18,818
Free Cash Flow
-15,272
-33,926
-4,274
-11,491
Cash
55,893
76,056
44,620
28,825
Basic Shares
40,984
40,180
39,480
39,009

Earnings Calls

Quarter EPS
2025-11-30
$0
2025-05-31
-$0.03
2025-02-28
$0.03
2024-11-30
-$0.04